Asakura Hiroyuki, Ohtsuka Masayuki, Ito Hiroshi, Kimura Fumio, Ambiru Satoshi, Shimizu Hiroaki, Togawa Akira, Yoshidome Hiroyuki, Kato Atsushi, Miyazaki Masaru
Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hepatogastroenterology. 2005 May-Jun;52(63):722-4.
We present a case of long-term survival in a patient that involved intrahepatic cholangiocarcinoma that metastasized to the paraaortic lymph nodes. A 62-year-old man underwent extended left hepatic lobectomy with caudate lobe resection, extrahepatic bile duct resection, portal vein resection and reconstruction, and middle hepatic vein resection and reconstruction with lymph node dissection for a liver tumor that was located in the caudate lobe. Histological examination of the resected specimen revealed moderately differentiated adenocarcinoma compatible with cholangiocarcinoma, and lymph node metastases were found in the area of the hepatoduodenal ligament and the paraaortic region. After surgical resection, recurrence was detected twice in the lymph nodes at the site of the left supraclavicular region. These recurrent tumors were completely eliminated by systemic chemotherapy with cisplatin or mitomycin C. The patient is now doing well 6 years and 5 months after surgical treatment. In this case, there was only one tumor, and the preoperative serum carbohydrate antigen 19-9 level was normal. In addition, heterozygosity was retained at the loci on chromosome 8p. These findings suggested that tumor in the present case was less aggressive, despite the nodal spread. The extensive surgical approach may have contributed to the long-term survival of this patient, while the recurrent tumor was sensitive to antitumoral agents.
我们报告了一例肝内胆管癌转移至主动脉旁淋巴结患者的长期生存病例。一名62岁男性因位于尾状叶的肝脏肿瘤接受了扩大左肝叶切除术,包括尾状叶切除、肝外胆管切除、门静脉切除及重建、肝中静脉切除及重建,并进行了淋巴结清扫。切除标本的组织学检查显示为中度分化腺癌,符合胆管癌,在肝十二指肠韧带和主动脉旁区域发现了淋巴结转移。手术切除后,左锁骨上区域淋巴结复发两次。这些复发性肿瘤通过顺铂或丝裂霉素C全身化疗被完全清除。患者在手术治疗后6年5个月情况良好。在该病例中,只有一个肿瘤,术前血清糖类抗原19-9水平正常。此外,8号染色体p位点保持杂合性。这些发现表明,尽管有淋巴结转移,本例肿瘤的侵袭性较低。广泛的手术方式可能有助于该患者的长期生存,而复发性肿瘤对抗肿瘤药物敏感。